Phase 3
💊 Investigational Drug / Biologic
NCT07104032
🟢 NCI-Designated Comprehensive Center
Mayo Clinic Comprehensive Cancer Center
📍 Rochester, Minnesota • Clinical Trial Intake Hotline: (800) 664-4580
Mayo Clinic Comprehensive Cancer Center operates across Minnesota, Arizona, and Florida, integrating advanced clinical trials with multidisciplinary patient treatment.
Active Clinical Trials at Mayo Clinic Comprehensive Cancer Center
Explore currently recruiting research protocols registered with the NIH ClinicalTrials.gov database:
Phase 2
💊 Investigational Drug / Biologic
NCT05541016
De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA
View Protocol & Screener ➔
Phase 3
💊 Investigational Drug / Biologic
NCT06170788
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
View Protocol & Screener ➔
Early Phase 1
💊 Investigational Drug / Biologic
NCT07273188
68Ga-FAPI-46 PET/CT for Assessing Small Bowel Fibrostenosis in Crohn's Disease
View Protocol & Screener ➔
Phase 3
🩺 Clinical Procedure Protocol
NCT07293650
PREcision MEDicine In Achalasia (PREMEDIA)
View Protocol & Screener ➔
Not Applicable
📊 Observational Clinical Research
NCT06880861
Investigating Memory and Physical Activity After Cancer Treatment in Survivors of Adolescent and Young Adult Cancers
View Protocol & Screener ➔
Phase 2
💊 Investigational Drug / Biologic
NCT06940297
Dasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma
View Protocol & Screener ➔
Protocol / Phase N/A
🔬 Diagnostic & Biomarker Protocol
NCT07031297
Upper Body Subcutaneous Exosome Release in Response to a Meal in Obesity
View Protocol & Screener ➔
Not Applicable
📊 Observational Clinical Research
NCT06675643
Digital Remote Monitoring of Immune Checkpoint Inhibitor Therapy Induced Toxicity Using the Vigilant App
View Protocol & Screener ➔
Not Applicable
📊 Observational Clinical Research
NCT01255748